Versant Venture Capital VI, L.P., 10% Owner at Tempest Therapeutics, Inc. (TPST), sold 1,175,998 shares at $1.10 ($1.4M) on 2024-08-12, disclosed to the SEC on 2024-08-12.
Open-market sale of $1.4M TPST by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.35 | 400,000 | $540K | 38.7% |
| 2 | $1.10 | 387,999 | $427K | 30.6% |
| 3 | $1.10 | 387,999 | $427K | 30.6% |
| Total | $1.19 avg | 1,175,998 | $1.4M | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| OYST | SELL | 2021-10-20 | $16.3M | — | Filing → |